Cargando…

Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinoma

Epithelial-mesenchymal transition (EMT) is an evolutionarily conserved developmental program that has been implicated in tumorigenesis and confers metastatic properties upon cancer cells. ZEB1 is a master transcription factor that activates the EMT process in various cancers. ZEB1 is reportedly degr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Xiao, Han, Yang, Zhang, Encheng, Wang, Yuqi, Zhang, Pingzhao, Wang, Chenji, Zhong, Lin, Li, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064142/ https://www.ncbi.nlm.nih.gov/pubmed/33833131 http://dx.doi.org/10.18632/aging.202823

Ejemplares similares

Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
por: Faust, Tyler, et al.
Publicado: (2019)

In vivo target protein degradation induced by PROTACs based on E3 ligase DCAF15
por: Li, Liang, et al.
Publicado: (2020)

FLASH protects ZEB1 from degradation and supports cancer cells' epithelial-to-mesenchymal transition
por: Abshire, C F, et al.
Publicado: (2016)

Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16
por: Zhang, Xiaoyu, et al.
Publicado: (2019)

FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition
por: Dong, Tianxiu, et al.
Publicado: (2016)

miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma
por: GUO, FEI, et al.
Publicado: (2014)

HOXD9 promotes epithelial–mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma
por: Lv, Xiupeng, et al.
Publicado: (2015)

Ovol2 induces mesenchymal–epithelial transition via targeting ZEB1 in osteosarcoma
por: Liu, Jijun, et al.
Publicado: (2018)

p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
por: Kim, Taewan, et al.
Publicado: (2011)

The role of epithelial–mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel‐resistant prostate cancer
por: Hanrahan, Karen, et al.
Publicado: (2017)

Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma
por: CHEN, WEIGUO, et al.
Publicado: (2013)

miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process
por: Pan, Yuliang, et al.
Publicado: (2016)

LDH-Apromotes epithelial–mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancer
por: Zhang, Yongjie, et al.
Publicado: (2018)

TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model
por: Leshem, Orit, et al.
Publicado: (2011)

Reversal of transforming growth factor-β induced epithelial-to-mesenchymal transition and the ZEB proteins
por: Das, Shreyasi, et al.
Publicado: (2012)

Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer
por: Prislei, Silvia, et al.
Publicado: (2015)

miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor
por: Pang, Xiaoli, et al.
Publicado: (2021)

Exploration of the Tunability of BRD4 Degradation by DCAF16 Trans-labelling Covalent Glues
por: Hassan, Muhammad Murtaza, et al.
Publicado: (2023)

MTA1, a Target of Resveratrol, Promotes Epithelial-Mesenchymal Transition of Endometriosis via ZEB2
por: Kong, Xiangyi, et al.
Publicado: (2020)

Long non‐coding RNA ZEB2‐AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple‐negative breast cancer by epigenetically activating ZEB2
por: Zhang, Guoxin, et al.
Publicado: (2019)

Overexpression of ZEB2‐AS1 promotes epithelial‐to‐mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma
por: Diao, Pengfei, et al.
Publicado: (2019)

lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial–mesenchymal transition by competitively binding miR-141-3p
por: Qian, Weibin, et al.
Publicado: (2019)

Aryl Sulfonamides Induce Degradation of Aryl Hydrocarbon Receptor Nuclear Translocator through CRL4(DCAF15) E3 Ligase
por: Kim, Sung Ah, et al.
Publicado: (2020)

PARK2 negatively regulates the metastasis and epithelial-mesenchymal transition of glioblastoma cells via ZEB1
por: Wang, Haiyang, et al.
Publicado: (2017)

Prognostic Role of Epithelial-Mesenchymal Transition Markers “E-Cadherin, β-Catenin, ZEB1, ZEB2 and p63” in Bladder Carcinoma
por: Moussa, Rabab Ahmed, et al.
Publicado: (2019)

Binding to DCAF1 distinguishes TASOR and SAMHD1 degradation by HIV-2 Vpx
por: Martin, Michaël M., et al.
Publicado: (2021)

HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer
por: Zhang, Wenjing, et al.
Publicado: (2015)

AB052. ZEB1 promotes vasculogenic mimicry formation in prostate cancer is associated with epithelial-mesenchymal transition
por: Wang, Hua, et al.
Publicado: (2017)

Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway
por: Das, Shreyas, et al.
Publicado: (2009)

Helicobacter pylori Initiates a Mesenchymal Transition through ZEB1 in Gastric Epithelial Cells
por: Baud, Jessica, et al.
Publicado: (2013)

RAE1 mediated ZEB1 expression promotes epithelial–mesenchymal transition in breast cancer
por: Oh, Ji Hoon, et al.
Publicado: (2019)

Polydatin inhibits ZEB1‐invoked epithelial‐mesenchymal transition in fructose‐induced liver fibrosis
por: Zhao, Xiaojuan, et al.
Publicado: (2020)

Human antigen R enhances the epithelial-mesenchymal transition via regulation of ZEB-1 in the human airway epithelium
por: Sun, Jian, et al.
Publicado: (2018)

Long non‐coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1
por: Wu, Qiong, et al.
Publicado: (2018)

Retraction statement: MicroRNA‐431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1‐mediated epithelial–mesenchymal transition
Publicado: (2022)

MTBP promotes migration and invasion by regulation of ZEB2-mediated epithelial–mesenchymal transition in lung cancer cells
por: Pan, Bo, et al.
Publicado: (2018)

Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition
por: Banno, Asoka, et al.
Publicado: (2016)

RETRACTED ARTICLE: The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2
por: Li, Chen, et al.
Publicado: (2017)

Retraction Note: The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2
por: Li, Chen, et al.
Publicado: (2023)

PLK1 and β-TrCP-Dependent Ubiquitination and Degradation of Rap1GAP Controls Cell Proliferation
por: Wang, Dejie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9qejqp2207e1io0fili1nv4vg4